{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "%matplotlib inline\n",
    "import pandas as pd\n",
    "pd.options.display.float_format = '${:,.0f}'.format\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 46,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "imsdata = pd.read_csv('imsdata3.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 47,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Molecule</th>\n",
       "      <th>ATC3</th>\n",
       "      <th>USC3</th>\n",
       "      <th>Form</th>\n",
       "      <th>Brand</th>\n",
       "      <th>Product</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>PATEXP</th>\n",
       "      <th>Strength</th>\n",
       "      <th>2009_Sales</th>\n",
       "      <th>2010_Sales</th>\n",
       "      <th>2011_Sales</th>\n",
       "      <th>2012_Sales</th>\n",
       "      <th>2013_Sales</th>\n",
       "      <th>2014_Sales</th>\n",
       "      <th>2015_Sales</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56100 FECAL SOFTENER</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>DOCUSATE SOD</td>\n",
       "      <td>TEVA PHARMACEUTICA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>$7,750</td>\n",
       "      <td>$18,614</td>\n",
       "      <td>$142</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56200 IRRITANT-STIMULANT LAX</td>\n",
       "      <td>R RECTALS,SYST</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>GLYCERIN</td>\n",
       "      <td>PRIVATE LABEL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>$302,843</td>\n",
       "      <td>$2,875,694</td>\n",
       "      <td>$1,923,251</td>\n",
       "      <td>$1,122,809</td>\n",
       "      <td>$1,366,640</td>\n",
       "      <td>$1,437,626</td>\n",
       "      <td>$1,215,119</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56300 BULK-PRODUCING LAX</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>KONSYL</td>\n",
       "      <td>KONSYL PHARMACEUT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100%</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>$49,825</td>\n",
       "      <td>$110,749</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56300 BULK-PRODUCING LAX</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>KONSYL</td>\n",
       "      <td>KONSYL PHARMACEUT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>28.30%</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>$109,692</td>\n",
       "      <td>$114,653</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56300 BULK-PRODUCING LAX</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>KONSYL</td>\n",
       "      <td>KONSYL PHARMACEUT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>$4,312</td>\n",
       "      <td>$51,489</td>\n",
       "      <td>$48,564</td>\n",
       "      <td>$35,569</td>\n",
       "      <td>$75,630</td>\n",
       "      <td>$541,313</td>\n",
       "      <td>$496,608</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Molecule                         ATC3                          USC3  \\\n",
       "0      NaN  A06A DRUGS FOR CONSTIPATION          56100 FECAL SOFTENER   \n",
       "1      NaN  A06A DRUGS FOR CONSTIPATION  56200 IRRITANT-STIMULANT LAX   \n",
       "2      NaN  A06A DRUGS FOR CONSTIPATION      56300 BULK-PRODUCING LAX   \n",
       "3      NaN  A06A DRUGS FOR CONSTIPATION      56300 BULK-PRODUCING LAX   \n",
       "4      NaN  A06A DRUGS FOR CONSTIPATION      56300 BULK-PRODUCING LAX   \n",
       "\n",
       "             Form  Brand       Product        Manufacturer PATEXP Strength  \\\n",
       "0         O ORALS  OTHER  DOCUSATE SOD  TEVA PHARMACEUTICA    NaN      NaN   \n",
       "1  R RECTALS,SYST  OTHER      GLYCERIN       PRIVATE LABEL    NaN      NaN   \n",
       "2         O ORALS  OTHER        KONSYL   KONSYL PHARMACEUT    NaN     100%   \n",
       "3         O ORALS  OTHER        KONSYL   KONSYL PHARMACEUT    NaN   28.30%   \n",
       "4         O ORALS  OTHER        KONSYL   KONSYL PHARMACEUT    NaN      NaN   \n",
       "\n",
       "  2009_Sales   2010_Sales   2011_Sales   2012_Sales   2013_Sales   2014_Sales  \\\n",
       "0    $7,750      $18,614         $142           NaN          NaN          NaN   \n",
       "1  $302,843   $2,875,694   $1,923,251   $1,122,809   $1,366,640   $1,437,626    \n",
       "2        NaN          NaN          NaN          NaN          NaN     $49,825    \n",
       "3        NaN          NaN          NaN          NaN          NaN    $109,692    \n",
       "4    $4,312      $51,489      $48,564      $35,569      $75,630     $541,313    \n",
       "\n",
       "    2015_Sales  \n",
       "0          NaN  \n",
       "1  $1,215,119   \n",
       "2    $110,749   \n",
       "3    $114,653   \n",
       "4    $496,608   "
      ]
     },
     "execution_count": 47,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "imsdata.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "imsdata['2009_Sales'] = imsdata['2009_Sales'].str.replace(',', '').str.replace('$', '').str.strip().astype(float)\n",
    "imsdata['2010_Sales'] = imsdata['2010_Sales'].str.replace(',', '').str.replace('$', '').str.strip().astype(float)\n",
    "imsdata['2011_Sales'] = imsdata['2011_Sales'].str.replace(',', '').str.replace('$', '').str.strip().astype(float)\n",
    "imsdata['2012_Sales'] = imsdata['2012_Sales'].str.replace(',', '').str.replace('$', '').str.strip().astype(float)\n",
    "imsdata['2013_Sales'] = imsdata['2013_Sales'].str.replace(',', '').str.replace('$', '').str.strip().astype(float)\n",
    "imsdata['2014_Sales'] = imsdata['2014_Sales'].str.replace(',', '').str.replace('$', '').str.strip().astype(float)\n",
    "imsdata['2015_Sales'] = imsdata['2015_Sales'].str.replace(',', '').str.replace('$', '').str.strip().astype(float)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Molecule</th>\n",
       "      <th>ATC3</th>\n",
       "      <th>USC3</th>\n",
       "      <th>Form</th>\n",
       "      <th>Brand</th>\n",
       "      <th>Product</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>PATEXP</th>\n",
       "      <th>Strength</th>\n",
       "      <th>2009_Sales</th>\n",
       "      <th>2010_Sales</th>\n",
       "      <th>2011_Sales</th>\n",
       "      <th>2012_Sales</th>\n",
       "      <th>2013_Sales</th>\n",
       "      <th>2014_Sales</th>\n",
       "      <th>2015_Sales</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56100 FECAL SOFTENER</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>DOCUSATE SOD</td>\n",
       "      <td>TEVA PHARMACEUTICA</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>$7,750</td>\n",
       "      <td>$18,614</td>\n",
       "      <td>$142</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56200 IRRITANT-STIMULANT LAX</td>\n",
       "      <td>R RECTALS,SYST</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>GLYCERIN</td>\n",
       "      <td>PRIVATE LABEL</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>$302,843</td>\n",
       "      <td>$2,875,694</td>\n",
       "      <td>$1,923,251</td>\n",
       "      <td>$1,122,809</td>\n",
       "      <td>$1,366,640</td>\n",
       "      <td>$1,437,626</td>\n",
       "      <td>$1,215,119</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56300 BULK-PRODUCING LAX</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>KONSYL</td>\n",
       "      <td>KONSYL PHARMACEUT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>100%</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$49,825</td>\n",
       "      <td>$110,749</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56300 BULK-PRODUCING LAX</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>KONSYL</td>\n",
       "      <td>KONSYL PHARMACEUT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>28.30%</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$109,692</td>\n",
       "      <td>$114,653</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>NaN</td>\n",
       "      <td>A06A DRUGS FOR CONSTIPATION</td>\n",
       "      <td>56300 BULK-PRODUCING LAX</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>OTHER</td>\n",
       "      <td>KONSYL</td>\n",
       "      <td>KONSYL PHARMACEUT</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>$4,312</td>\n",
       "      <td>$51,489</td>\n",
       "      <td>$48,564</td>\n",
       "      <td>$35,569</td>\n",
       "      <td>$75,630</td>\n",
       "      <td>$541,313</td>\n",
       "      <td>$496,608</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "  Molecule                         ATC3                          USC3  \\\n",
       "0      NaN  A06A DRUGS FOR CONSTIPATION          56100 FECAL SOFTENER   \n",
       "1      NaN  A06A DRUGS FOR CONSTIPATION  56200 IRRITANT-STIMULANT LAX   \n",
       "2      NaN  A06A DRUGS FOR CONSTIPATION      56300 BULK-PRODUCING LAX   \n",
       "3      NaN  A06A DRUGS FOR CONSTIPATION      56300 BULK-PRODUCING LAX   \n",
       "4      NaN  A06A DRUGS FOR CONSTIPATION      56300 BULK-PRODUCING LAX   \n",
       "\n",
       "             Form  Brand       Product        Manufacturer PATEXP Strength  \\\n",
       "0         O ORALS  OTHER  DOCUSATE SOD  TEVA PHARMACEUTICA    NaN      NaN   \n",
       "1  R RECTALS,SYST  OTHER      GLYCERIN       PRIVATE LABEL    NaN      NaN   \n",
       "2         O ORALS  OTHER        KONSYL   KONSYL PHARMACEUT    NaN     100%   \n",
       "3         O ORALS  OTHER        KONSYL   KONSYL PHARMACEUT    NaN   28.30%   \n",
       "4         O ORALS  OTHER        KONSYL   KONSYL PHARMACEUT    NaN      NaN   \n",
       "\n",
       "   2009_Sales  2010_Sales  2011_Sales  2012_Sales  2013_Sales  2014_Sales  \\\n",
       "0      $7,750     $18,614        $142        $nan        $nan        $nan   \n",
       "1    $302,843  $2,875,694  $1,923,251  $1,122,809  $1,366,640  $1,437,626   \n",
       "2        $nan        $nan        $nan        $nan        $nan     $49,825   \n",
       "3        $nan        $nan        $nan        $nan        $nan    $109,692   \n",
       "4      $4,312     $51,489     $48,564     $35,569     $75,630    $541,313   \n",
       "\n",
       "   2015_Sales  \n",
       "0        $nan  \n",
       "1  $1,215,119  \n",
       "2    $110,749  \n",
       "3    $114,653  \n",
       "4    $496,608  "
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "imsdata.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "molecule = 'FENOFIBRATE'\n",
    "strength = ['145MG', '48MG']\n",
    "drugtype = ['GENERIC']\n",
    "form = 'O ORALS'"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 51,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>Molecule</th>\n",
       "      <th>ATC3</th>\n",
       "      <th>USC3</th>\n",
       "      <th>Form</th>\n",
       "      <th>Brand</th>\n",
       "      <th>Product</th>\n",
       "      <th>Manufacturer</th>\n",
       "      <th>PATEXP</th>\n",
       "      <th>Strength</th>\n",
       "      <th>2009_Sales</th>\n",
       "      <th>2010_Sales</th>\n",
       "      <th>2011_Sales</th>\n",
       "      <th>2012_Sales</th>\n",
       "      <th>2013_Sales</th>\n",
       "      <th>2014_Sales</th>\n",
       "      <th>2015_Sales</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>13806</th>\n",
       "      <td>FENOFIBRATE</td>\n",
       "      <td>C10A CHOLEST&amp;TRIGLY.REGULATOR</td>\n",
       "      <td>32100 CHOLESTEROL RED</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>BRAND</td>\n",
       "      <td>TRICOR</td>\n",
       "      <td>ABBVIE INC.</td>\n",
       "      <td>Apr-02</td>\n",
       "      <td>145MG</td>\n",
       "      <td>$140,700,914</td>\n",
       "      <td>$1,357,527,213</td>\n",
       "      <td>$1,335,165,105</td>\n",
       "      <td>$1,076,304,398</td>\n",
       "      <td>$126,002,678</td>\n",
       "      <td>$121,215,552</td>\n",
       "      <td>$90,547,045</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13807</th>\n",
       "      <td>FENOFIBRATE</td>\n",
       "      <td>C10A CHOLEST&amp;TRIGLY.REGULATOR</td>\n",
       "      <td>32100 CHOLESTEROL RED</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>BRAND</td>\n",
       "      <td>TRICOR</td>\n",
       "      <td>ABBVIE INC.</td>\n",
       "      <td>Apr-02</td>\n",
       "      <td>48MG</td>\n",
       "      <td>$7,056,250</td>\n",
       "      <td>$70,240,209</td>\n",
       "      <td>$70,967,942</td>\n",
       "      <td>$58,842,306</td>\n",
       "      <td>$4,332,930</td>\n",
       "      <td>$3,473,121</td>\n",
       "      <td>$1,940,280</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13824</th>\n",
       "      <td>FENOFIBRATE</td>\n",
       "      <td>C10A CHOLEST&amp;TRIGLY.REGULATOR</td>\n",
       "      <td>32100 CHOLESTEROL RED</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>GENERIC</td>\n",
       "      <td>FENOFIBRATE</td>\n",
       "      <td>AMERICAN HLTH PKG</td>\n",
       "      <td>NaN</td>\n",
       "      <td>145MG</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$1,361,154</td>\n",
       "      <td>$1,264,923</td>\n",
       "      <td>$700,634</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13827</th>\n",
       "      <td>FENOFIBRATE</td>\n",
       "      <td>C10A CHOLEST&amp;TRIGLY.REGULATOR</td>\n",
       "      <td>32100 CHOLESTEROL RED</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>GENERIC</td>\n",
       "      <td>FENOFIBRATE</td>\n",
       "      <td>AMERICAN HLTH PKG</td>\n",
       "      <td>NaN</td>\n",
       "      <td>48MG</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$189,841</td>\n",
       "      <td>$181,249</td>\n",
       "      <td>$115,977</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13833</th>\n",
       "      <td>FENOFIBRATE</td>\n",
       "      <td>C10A CHOLEST&amp;TRIGLY.REGULATOR</td>\n",
       "      <td>32100 CHOLESTEROL RED</td>\n",
       "      <td>O ORALS</td>\n",
       "      <td>GENERIC</td>\n",
       "      <td>FENOFIBRATE</td>\n",
       "      <td>A-S MEDICATION</td>\n",
       "      <td>NaN</td>\n",
       "      <td>48MG</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$4,340</td>\n",
       "      <td>$4,903</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          Molecule                           ATC3                   USC3  \\\n",
       "13806  FENOFIBRATE  C10A CHOLEST&TRIGLY.REGULATOR  32100 CHOLESTEROL RED   \n",
       "13807  FENOFIBRATE  C10A CHOLEST&TRIGLY.REGULATOR  32100 CHOLESTEROL RED   \n",
       "13824  FENOFIBRATE  C10A CHOLEST&TRIGLY.REGULATOR  32100 CHOLESTEROL RED   \n",
       "13827  FENOFIBRATE  C10A CHOLEST&TRIGLY.REGULATOR  32100 CHOLESTEROL RED   \n",
       "13833  FENOFIBRATE  C10A CHOLEST&TRIGLY.REGULATOR  32100 CHOLESTEROL RED   \n",
       "\n",
       "          Form    Brand      Product       Manufacturer  PATEXP Strength  \\\n",
       "13806  O ORALS    BRAND       TRICOR        ABBVIE INC.  Apr-02    145MG   \n",
       "13807  O ORALS    BRAND       TRICOR        ABBVIE INC.  Apr-02     48MG   \n",
       "13824  O ORALS  GENERIC  FENOFIBRATE  AMERICAN HLTH PKG     NaN    145MG   \n",
       "13827  O ORALS  GENERIC  FENOFIBRATE  AMERICAN HLTH PKG     NaN     48MG   \n",
       "13833  O ORALS  GENERIC  FENOFIBRATE     A-S MEDICATION     NaN     48MG   \n",
       "\n",
       "        2009_Sales     2010_Sales     2011_Sales     2012_Sales   2013_Sales  \\\n",
       "13806 $140,700,914 $1,357,527,213 $1,335,165,105 $1,076,304,398 $126,002,678   \n",
       "13807   $7,056,250    $70,240,209    $70,967,942    $58,842,306   $4,332,930   \n",
       "13824         $nan           $nan           $nan           $nan   $1,361,154   \n",
       "13827         $nan           $nan           $nan           $nan     $189,841   \n",
       "13833         $nan           $nan           $nan           $nan         $nan   \n",
       "\n",
       "        2014_Sales  2015_Sales  \n",
       "13806 $121,215,552 $90,547,045  \n",
       "13807   $3,473,121  $1,940,280  \n",
       "13824   $1,264,923    $700,634  \n",
       "13827     $181,249    $115,977  \n",
       "13833       $4,340      $4,903  "
      ]
     },
     "execution_count": 51,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "selected_df = imsdata[(imsdata.Strength.isin(strength)) & (imsdata.Form == form) & (imsdata.Molecule == molecule)]\n",
    "selected_df.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 52,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Anaconda3\\lib\\site-packages\\ipykernel\\__main__.py:1: SettingWithCopyWarning: \n",
      "A value is trying to be set on a copy of a slice from a DataFrame.\n",
      "Try using .loc[row_indexer,col_indexer] = value instead\n",
      "\n",
      "See the caveats in the documentation: http://pandas.pydata.org/pandas-docs/stable/indexing.html#indexing-view-versus-copy\n",
      "  if __name__ == '__main__':\n"
     ]
    }
   ],
   "source": [
    "selected_df['2015_Sales'] = selected_df['2015_Sales'] * 4/3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 53,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>2009_Sales</th>\n",
       "      <th>2010_Sales</th>\n",
       "      <th>2011_Sales</th>\n",
       "      <th>2012_Sales</th>\n",
       "      <th>2013_Sales</th>\n",
       "      <th>2014_Sales</th>\n",
       "      <th>2015_Sales</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Brand</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>BRAND</th>\n",
       "      <td>$147,757,164</td>\n",
       "      <td>$1,427,767,422</td>\n",
       "      <td>$1,406,133,047</td>\n",
       "      <td>$1,135,146,704</td>\n",
       "      <td>$130,335,608</td>\n",
       "      <td>$124,688,673</td>\n",
       "      <td>$123,316,433</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>GENERIC</th>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$117,345,935</td>\n",
       "      <td>$602,210,023</td>\n",
       "      <td>$468,418,121</td>\n",
       "      <td>$354,221,520</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "          2009_Sales     2010_Sales     2011_Sales     2012_Sales  \\\n",
       "Brand                                                               \n",
       "BRAND   $147,757,164 $1,427,767,422 $1,406,133,047 $1,135,146,704   \n",
       "GENERIC         $nan           $nan           $nan   $117,345,935   \n",
       "\n",
       "          2013_Sales   2014_Sales   2015_Sales  \n",
       "Brand                                           \n",
       "BRAND   $130,335,608 $124,688,673 $123,316,433  \n",
       "GENERIC $602,210,023 $468,418,121 $354,221,520  "
      ]
     },
     "execution_count": 53,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "bybrand_df = selected_df.groupby('Brand')\n",
    "bybrand_df.sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 54,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>2009_Sales</th>\n",
       "      <th>2010_Sales</th>\n",
       "      <th>2011_Sales</th>\n",
       "      <th>2012_Sales</th>\n",
       "      <th>2013_Sales</th>\n",
       "      <th>2014_Sales</th>\n",
       "      <th>2015_Sales</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>Product</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>FENOFIBRATE</th>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$117,345,935</td>\n",
       "      <td>$602,210,023</td>\n",
       "      <td>$468,418,121</td>\n",
       "      <td>$354,221,520</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>TRICOR</th>\n",
       "      <td>$147,757,164</td>\n",
       "      <td>$1,427,767,422</td>\n",
       "      <td>$1,406,133,047</td>\n",
       "      <td>$1,135,146,704</td>\n",
       "      <td>$130,335,608</td>\n",
       "      <td>$124,688,673</td>\n",
       "      <td>$123,316,433</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "              2009_Sales     2010_Sales     2011_Sales     2012_Sales  \\\n",
       "Product                                                                 \n",
       "FENOFIBRATE         $nan           $nan           $nan   $117,345,935   \n",
       "TRICOR      $147,757,164 $1,427,767,422 $1,406,133,047 $1,135,146,704   \n",
       "\n",
       "              2013_Sales   2014_Sales   2015_Sales  \n",
       "Product                                             \n",
       "FENOFIBRATE $602,210,023 $468,418,121 $354,221,520  \n",
       "TRICOR      $130,335,608 $124,688,673 $123,316,433  "
      ]
     },
     "execution_count": 54,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "byproduct_df = selected_df.groupby('Product')\n",
    "byproduct_df.sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAagAAAEuCAYAAADbW4YFAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nXKDMzCyX/n9XCjF/l4fo6gAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0xd89bb70>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ax = bybrand_df.sum().transpose().plot(kind='bar', stacked=True)\n",
    "ax.yaxis.set_major_formatter(plt.FuncFormatter(lambda x, p: format(int(x), ',')))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAagAAAEuCAYAAADbW4YFAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0xd88ff98>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ax = byproduct_df.sum().transpose().plot(kind='bar', stacked=True)\n",
    "ax.yaxis.set_major_formatter(plt.FuncFormatter(lambda x, p: format(int(x), ',')))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.legend.Legend at 0x95a4a58>"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAmQAAAEuCAYAAAAgOg4rAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\naMuAdVAAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x1388358>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "ax = bymanu_df.sum().transpose().plot(kind='bar', stacked=True)\n",
    "ax.yaxis.set_major_formatter(plt.FuncFormatter(lambda x, p: format(int(x), ',')))\n",
    "plt.legend(bbox_to_anchor=(1.05, 1), loc=2, borderaxespad=0.) "
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "type_df = imsdata.groupby('ATC3')\n",
    "typesum_df = type_df.sum()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 61,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>2009_Sales</th>\n",
       "      <th>2010_Sales</th>\n",
       "      <th>2011_Sales</th>\n",
       "      <th>2012_Sales</th>\n",
       "      <th>2013_Sales</th>\n",
       "      <th>2014_Sales</th>\n",
       "      <th>2015_Sales</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>ATC3</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>A10C HUMAN INSULIN+ANALOGUES</th>\n",
       "      <td>$742,079,926</td>\n",
       "      <td>$8,839,139,374</td>\n",
       "      <td>$10,368,543,405</td>\n",
       "      <td>$12,029,319,586</td>\n",
       "      <td>$15,409,739,180</td>\n",
       "      <td>$20,472,938,207</td>\n",
       "      <td>$18,267,383,173</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>L04B ANTI-TNF PRODUCTS</th>\n",
       "      <td>$901,405,875</td>\n",
       "      <td>$10,307,786,502</td>\n",
       "      <td>$11,599,115,081</td>\n",
       "      <td>$13,291,287,167</td>\n",
       "      <td>$15,632,559,151</td>\n",
       "      <td>$19,523,048,388</td>\n",
       "      <td>$17,611,642,263</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>J05B ANTIVIRALS EXCL ANTI-HIV</th>\n",
       "      <td>$364,628,590</td>\n",
       "      <td>$3,259,218,483</td>\n",
       "      <td>$3,783,147,071</td>\n",
       "      <td>$4,416,735,597</td>\n",
       "      <td>$3,583,822,947</td>\n",
       "      <td>$14,057,523,775</td>\n",
       "      <td>$15,783,499,059</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>J05C HIV ANTIVIRALS</th>\n",
       "      <td>$838,449,602</td>\n",
       "      <td>$9,361,722,160</td>\n",
       "      <td>$10,425,568,102</td>\n",
       "      <td>$11,362,532,422</td>\n",
       "      <td>$12,481,200,605</td>\n",
       "      <td>$14,342,715,015</td>\n",
       "      <td>$12,249,956,153</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>N05A ANTIPSYCHOTICS</th>\n",
       "      <td>$1,459,445,588</td>\n",
       "      <td>$16,313,933,635</td>\n",
       "      <td>$18,445,943,730</td>\n",
       "      <td>$13,272,796,233</td>\n",
       "      <td>$12,363,887,855</td>\n",
       "      <td>$14,595,378,779</td>\n",
       "      <td>$10,949,869,451</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>L01G MAB ANTINEOPLASTICS</th>\n",
       "      <td>$775,466,245</td>\n",
       "      <td>$8,327,409,055</td>\n",
       "      <td>$8,585,636,903</td>\n",
       "      <td>$9,130,107,622</td>\n",
       "      <td>$9,853,747,190</td>\n",
       "      <td>$11,230,992,713</td>\n",
       "      <td>$9,945,900,325</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>C10A CHOLEST&amp;TRIGLY.REGULATOR</th>\n",
       "      <td>$1,611,076,334</td>\n",
       "      <td>$17,869,762,169</td>\n",
       "      <td>$19,654,414,518</td>\n",
       "      <td>$15,190,739,932</td>\n",
       "      <td>$12,535,464,617</td>\n",
       "      <td>$12,694,372,883</td>\n",
       "      <td>$9,394,372,968</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>N03A ANTI-EPILEPTICS</th>\n",
       "      <td>$562,699,135</td>\n",
       "      <td>$5,744,242,911</td>\n",
       "      <td>$6,023,663,290</td>\n",
       "      <td>$6,066,664,715</td>\n",
       "      <td>$7,193,795,755</td>\n",
       "      <td>$8,509,607,219</td>\n",
       "      <td>$7,436,970,595</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>L03A IMMUNOSTIM AG EX INTFRON</th>\n",
       "      <td>$568,608,559</td>\n",
       "      <td>$6,613,290,644</td>\n",
       "      <td>$7,725,432,494</td>\n",
       "      <td>$8,179,401,022</td>\n",
       "      <td>$8,604,649,157</td>\n",
       "      <td>$9,052,907,185</td>\n",
       "      <td>$7,426,129,886</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>L01H PROTEIN KINASE INH A-NEO</th>\n",
       "      <td>$241,684,926</td>\n",
       "      <td>$2,955,797,379</td>\n",
       "      <td>$3,661,904,516</td>\n",
       "      <td>$4,602,790,110</td>\n",
       "      <td>$5,735,995,613</td>\n",
       "      <td>$7,479,903,265</td>\n",
       "      <td>$6,991,640,910</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>N06B PSYCHOSTIMULANTS</th>\n",
       "      <td>$597,512,843</td>\n",
       "      <td>$6,818,116,496</td>\n",
       "      <td>$7,976,391,249</td>\n",
       "      <td>$8,930,754,357</td>\n",
       "      <td>$8,362,893,489</td>\n",
       "      <td>$8,325,607,275</td>\n",
       "      <td>$6,684,808,696</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>N02A NARCOTIC ANALGESICS</th>\n",
       "      <td>$811,640,663</td>\n",
       "      <td>$8,463,964,080</td>\n",
       "      <td>$8,334,870,709</td>\n",
       "      <td>$8,198,608,478</td>\n",
       "      <td>$8,283,624,184</td>\n",
       "      <td>$8,855,397,919</td>\n",
       "      <td>$6,667,318,523</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>R03F B2-STIMULANTS+CORTICOIDS</th>\n",
       "      <td>$549,520,533</td>\n",
       "      <td>$6,049,238,716</td>\n",
       "      <td>$6,264,401,811</td>\n",
       "      <td>$6,595,761,925</td>\n",
       "      <td>$7,537,576,296</td>\n",
       "      <td>$8,152,466,357</td>\n",
       "      <td>$6,642,387,359</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A02B ANTIULCERANTS</th>\n",
       "      <td>$1,250,344,211</td>\n",
       "      <td>$12,899,609,092</td>\n",
       "      <td>$10,995,409,144</td>\n",
       "      <td>$10,220,295,809</td>\n",
       "      <td>$10,533,571,606</td>\n",
       "      <td>$9,718,105,249</td>\n",
       "      <td>$6,419,058,846</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>L04X OTHER IMMUNOSUPPRESSANTS</th>\n",
       "      <td>$253,225,425</td>\n",
       "      <td>$2,814,007,313</td>\n",
       "      <td>$3,409,174,388</td>\n",
       "      <td>$4,006,017,323</td>\n",
       "      <td>$5,130,979,450</td>\n",
       "      <td>$6,842,505,598</td>\n",
       "      <td>$6,038,477,363</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A10N DPP-IV INHIB ANTIDIAB</th>\n",
       "      <td>$209,290,894</td>\n",
       "      <td>$2,660,315,158</td>\n",
       "      <td>$3,490,233,933</td>\n",
       "      <td>$4,427,911,104</td>\n",
       "      <td>$5,290,779,829</td>\n",
       "      <td>$6,477,965,596</td>\n",
       "      <td>$5,802,403,288</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>N07X ALL OTHER CNS DRUGS</th>\n",
       "      <td>$78,479,069</td>\n",
       "      <td>$1,056,385,597</td>\n",
       "      <td>$1,334,038,125</td>\n",
       "      <td>$1,654,719,703</td>\n",
       "      <td>$3,084,354,356</td>\n",
       "      <td>$5,640,242,676</td>\n",
       "      <td>$5,074,300,641</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>N06A ANTIDEPRESS.&amp; MOOD STAB.</th>\n",
       "      <td>$1,114,790,703</td>\n",
       "      <td>$11,930,272,075</td>\n",
       "      <td>$11,288,913,834</td>\n",
       "      <td>$9,613,659,445</td>\n",
       "      <td>$9,302,004,426</td>\n",
       "      <td>$6,868,586,539</td>\n",
       "      <td>$4,257,404,931</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>G03A HORMONAL CONTRACEPT SYST</th>\n",
       "      <td>$441,972,265</td>\n",
       "      <td>$4,832,167,207</td>\n",
       "      <td>$5,197,518,929</td>\n",
       "      <td>$5,379,145,035</td>\n",
       "      <td>$5,386,697,726</td>\n",
       "      <td>$5,346,349,146</td>\n",
       "      <td>$4,176,768,585</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>R03G ANTICHOLINERGIC+B2-STIM</th>\n",
       "      <td>$287,234,413</td>\n",
       "      <td>$3,351,411,481</td>\n",
       "      <td>$3,878,841,608</td>\n",
       "      <td>$4,131,978,073</td>\n",
       "      <td>$4,412,799,409</td>\n",
       "      <td>$4,733,172,409</td>\n",
       "      <td>$3,898,155,670</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>L03B INTERFERONS</th>\n",
       "      <td>$312,838,538</td>\n",
       "      <td>$3,546,741,377</td>\n",
       "      <td>$3,858,289,859</td>\n",
       "      <td>$4,252,865,062</td>\n",
       "      <td>$4,825,627,668</td>\n",
       "      <td>$4,713,002,069</td>\n",
       "      <td>$3,751,979,572</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>J07E VIRAL VACCINES</th>\n",
       "      <td>$250,298,291</td>\n",
       "      <td>$3,136,738,705</td>\n",
       "      <td>$3,320,007,856</td>\n",
       "      <td>$3,734,589,368</td>\n",
       "      <td>$4,178,961,033</td>\n",
       "      <td>$4,666,146,125</td>\n",
       "      <td>$3,544,011,070</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>T02D DIABETES TEST</th>\n",
       "      <td>$352,498,215</td>\n",
       "      <td>$3,740,369,928</td>\n",
       "      <td>$3,794,634,292</td>\n",
       "      <td>$3,758,750,328</td>\n",
       "      <td>$3,966,071,363</td>\n",
       "      <td>$4,155,525,929</td>\n",
       "      <td>$3,308,853,329</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>B03C ERYTHROPOIETIN PRODUCTS</th>\n",
       "      <td>$596,696,011</td>\n",
       "      <td>$6,119,582,714</td>\n",
       "      <td>$5,146,513,592</td>\n",
       "      <td>$4,175,084,291</td>\n",
       "      <td>$4,153,201,377</td>\n",
       "      <td>$4,226,034,914</td>\n",
       "      <td>$3,185,703,803</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>B01F DIRECT FACTOR XA INHIBITORS</th>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$17,031,766</td>\n",
       "      <td>$256,391,468</td>\n",
       "      <td>$1,125,280,477</td>\n",
       "      <td>$2,616,374,746</td>\n",
       "      <td>$3,068,029,527</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>R03A B2-STIMULANTS</th>\n",
       "      <td>$284,106,805</td>\n",
       "      <td>$2,935,422,804</td>\n",
       "      <td>$3,133,424,137</td>\n",
       "      <td>$3,239,213,273</td>\n",
       "      <td>$3,303,831,241</td>\n",
       "      <td>$3,561,669,607</td>\n",
       "      <td>$2,928,384,141</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>R03D CORTICOIDS</th>\n",
       "      <td>$304,359,876</td>\n",
       "      <td>$2,608,827,766</td>\n",
       "      <td>$2,891,419,706</td>\n",
       "      <td>$3,083,902,172</td>\n",
       "      <td>$3,444,502,714</td>\n",
       "      <td>$3,681,024,019</td>\n",
       "      <td>$2,831,089,879</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A10S GLP-1 AGONIST ANTIDIAB</th>\n",
       "      <td>$61,978,790</td>\n",
       "      <td>$844,787,962</td>\n",
       "      <td>$1,204,950,250</td>\n",
       "      <td>$1,603,099,752</td>\n",
       "      <td>$2,077,394,829</td>\n",
       "      <td>$2,673,656,401</td>\n",
       "      <td>$2,659,330,472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A07E INTESTINAL ANTI-INFLAMM</th>\n",
       "      <td>$168,280,644</td>\n",
       "      <td>$1,950,885,436</td>\n",
       "      <td>$2,216,173,210</td>\n",
       "      <td>$2,215,923,998</td>\n",
       "      <td>$2,452,171,127</td>\n",
       "      <td>$2,825,894,007</td>\n",
       "      <td>$2,582,281,872</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>G04E ERECTILE DYSFUNCTION PRD</th>\n",
       "      <td>$196,471,259</td>\n",
       "      <td>$2,057,606,145</td>\n",
       "      <td>$2,162,266,078</td>\n",
       "      <td>$2,236,891,610</td>\n",
       "      <td>$2,572,906,391</td>\n",
       "      <td>$2,966,493,044</td>\n",
       "      <td>$2,471,040,341</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>G03X OTH.SEX HORM.&amp;SIMILAR</th>\n",
       "      <td>$702,545</td>\n",
       "      <td>$7,124,438</td>\n",
       "      <td>$6,802,315</td>\n",
       "      <td>$6,929,617</td>\n",
       "      <td>$6,114,339</td>\n",
       "      <td>$4,958,442</td>\n",
       "      <td>$4,709,047</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>K02B STARCHES</th>\n",
       "      <td>$1,606,515</td>\n",
       "      <td>$20,706,084</td>\n",
       "      <td>$20,642,050</td>\n",
       "      <td>$22,368,919</td>\n",
       "      <td>$14,083,080</td>\n",
       "      <td>$6,239,741</td>\n",
       "      <td>$4,272,752</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>J03A SYSTEMIC SULPHONAMIDES</th>\n",
       "      <td>$522,225</td>\n",
       "      <td>$5,843,966</td>\n",
       "      <td>$6,032,996</td>\n",
       "      <td>$6,039,299</td>\n",
       "      <td>$6,646,640</td>\n",
       "      <td>$5,702,515</td>\n",
       "      <td>$4,054,874</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>K05A IRRIGATING SOLUTIONS</th>\n",
       "      <td>$264,094</td>\n",
       "      <td>$2,976,474</td>\n",
       "      <td>$2,938,666</td>\n",
       "      <td>$2,839,832</td>\n",
       "      <td>$2,753,392</td>\n",
       "      <td>$2,995,908</td>\n",
       "      <td>$3,620,448</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>T01G RADIODIAGNOSTIC AGENTS</th>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$639,600</td>\n",
       "      <td>$3,456,960</td>\n",
       "      <td>$2,982,200</td>\n",
       "      <td>$3,216,200</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>R03C N-STEROIDAL RESP A-INFL</th>\n",
       "      <td>$251,509</td>\n",
       "      <td>$2,281,054</td>\n",
       "      <td>$1,618,751</td>\n",
       "      <td>$1,732,835</td>\n",
       "      <td>$1,871,087</td>\n",
       "      <td>$2,186,784</td>\n",
       "      <td>$2,714,422</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A07X OTHER ANTIDIARRHOEALS</th>\n",
       "      <td>$1,274</td>\n",
       "      <td>$53,900</td>\n",
       "      <td>$35,729</td>\n",
       "      <td>$46,092</td>\n",
       "      <td>$1,208,338</td>\n",
       "      <td>$2,550,117</td>\n",
       "      <td>$2,320,079</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>K01A ELECTROLYTE SOLN=&gt;100ML</th>\n",
       "      <td>$382,097</td>\n",
       "      <td>$3,764,913</td>\n",
       "      <td>$2,326,795</td>\n",
       "      <td>$2,198,333</td>\n",
       "      <td>$526,589</td>\n",
       "      <td>$1,208,929</td>\n",
       "      <td>$2,174,818</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>G01D GYNAECOLOG ANTISEPTICS</th>\n",
       "      <td>$33,917</td>\n",
       "      <td>$316,459</td>\n",
       "      <td>$4,376,518</td>\n",
       "      <td>$1,415,275</td>\n",
       "      <td>$1,431,201</td>\n",
       "      <td>$2,096,224</td>\n",
       "      <td>$1,858,737</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>C05B VARICOSE THERAPY,TOPICAL</th>\n",
       "      <td>$449,584</td>\n",
       "      <td>$2,792,942</td>\n",
       "      <td>$3,973,397</td>\n",
       "      <td>$8,062,444</td>\n",
       "      <td>$4,830,263</td>\n",
       "      <td>$2,193,026</td>\n",
       "      <td>$1,377,375</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>J06G SPECF IMM-GLOB ANTI-BACT</th>\n",
       "      <td>$712,770</td>\n",
       "      <td>$4,821,608</td>\n",
       "      <td>$7,102,153</td>\n",
       "      <td>$4,860,107</td>\n",
       "      <td>$2,639,025</td>\n",
       "      <td>$1,717,991</td>\n",
       "      <td>$1,332,386</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>N06D NOOTROPICS</th>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$38,187</td>\n",
       "      <td>$301,779</td>\n",
       "      <td>$771,328</td>\n",
       "      <td>$1,131,840</td>\n",
       "      <td>$1,013,603</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>C02B A-HYPERT(NON VEG)+DIURET</th>\n",
       "      <td>$106,147</td>\n",
       "      <td>$1,003,446</td>\n",
       "      <td>$1,092,611</td>\n",
       "      <td>$1,242,050</td>\n",
       "      <td>$1,250,800</td>\n",
       "      <td>$1,167,913</td>\n",
       "      <td>$738,118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>K01B STANDARD SOLUTIONS</th>\n",
       "      <td>$78,477</td>\n",
       "      <td>$1,209,659</td>\n",
       "      <td>$730,649</td>\n",
       "      <td>$579,845</td>\n",
       "      <td>$535,163</td>\n",
       "      <td>$887,939</td>\n",
       "      <td>$693,645</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>K01E AMINO-ACID SOLUTIONS</th>\n",
       "      <td>$14,748</td>\n",
       "      <td>$278,890</td>\n",
       "      <td>$314,121</td>\n",
       "      <td>$226,097</td>\n",
       "      <td>$418,660</td>\n",
       "      <td>$669,609</td>\n",
       "      <td>$637,357</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>H03C IODINE PREPARATIONS</th>\n",
       "      <td>$37,436</td>\n",
       "      <td>$1,412,212</td>\n",
       "      <td>$2,164,102</td>\n",
       "      <td>$1,304,628</td>\n",
       "      <td>$645,194</td>\n",
       "      <td>$1,034,800</td>\n",
       "      <td>$617,472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>K02A DEXTRANS</th>\n",
       "      <td>$138,420</td>\n",
       "      <td>$1,774,903</td>\n",
       "      <td>$1,338,152</td>\n",
       "      <td>$1,504,886</td>\n",
       "      <td>$1,104,920</td>\n",
       "      <td>$354,925</td>\n",
       "      <td>$425,073</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A02C OTH STOMACH DISORDER PRD</th>\n",
       "      <td>$27,576</td>\n",
       "      <td>$438,167</td>\n",
       "      <td>$472,649</td>\n",
       "      <td>$377,113</td>\n",
       "      <td>$400,188</td>\n",
       "      <td>$377,728</td>\n",
       "      <td>$275,215</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>K07A PERFUSION SOLUTIONS</th>\n",
       "      <td>$28,917</td>\n",
       "      <td>$191,961</td>\n",
       "      <td>$23,940</td>\n",
       "      <td>$29,616</td>\n",
       "      <td>$28,127</td>\n",
       "      <td>$140,705</td>\n",
       "      <td>$156,979</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>J01L CARBENICILLIN+SIMIL.TYPE</th>\n",
       "      <td>$981,542</td>\n",
       "      <td>$9,009,489</td>\n",
       "      <td>$6,086,181</td>\n",
       "      <td>$3,133,312</td>\n",
       "      <td>$1,828,937</td>\n",
       "      <td>$2,100,345</td>\n",
       "      <td>$9,267</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>K04B STANDARD SOLUTION &lt;100ML</th>\n",
       "      <td>$25,860</td>\n",
       "      <td>$216,454</td>\n",
       "      <td>$2,153,489</td>\n",
       "      <td>$13,142</td>\n",
       "      <td>$5,086</td>\n",
       "      <td>$4,071</td>\n",
       "      <td>$8,228</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>P03B INSECTICIDES &amp; REPELLENTS</th>\n",
       "      <td>$nan</td>\n",
       "      <td>$319</td>\n",
       "      <td>$525</td>\n",
       "      <td>$2,137</td>\n",
       "      <td>$2,152</td>\n",
       "      <td>$3,009</td>\n",
       "      <td>$2,580</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>C02C RAUWLF ALK+OTH A-HY HERB</th>\n",
       "      <td>$95,011</td>\n",
       "      <td>$1,037,018</td>\n",
       "      <td>$888,547</td>\n",
       "      <td>$549,178</td>\n",
       "      <td>$1,391</td>\n",
       "      <td>$448</td>\n",
       "      <td>$109</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>K04C CALORIC SOLUTIONS &lt;100ML</th>\n",
       "      <td>$3</td>\n",
       "      <td>$218</td>\n",
       "      <td>$35</td>\n",
       "      <td>$90</td>\n",
       "      <td>$113</td>\n",
       "      <td>$7</td>\n",
       "      <td>$89</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A03E A-SPASMA COMBINATIONS</th>\n",
       "      <td>$20,878</td>\n",
       "      <td>$225,224</td>\n",
       "      <td>$275,724</td>\n",
       "      <td>$348,084</td>\n",
       "      <td>$139,144</td>\n",
       "      <td>$538</td>\n",
       "      <td>$50</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A10D ANIMAL INSULINS</th>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$11,358</td>\n",
       "      <td>$nan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>A15A APPETITE STIMULANTS</th>\n",
       "      <td>$8,207</td>\n",
       "      <td>$106,213</td>\n",
       "      <td>$37,557</td>\n",
       "      <td>$343</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>J01B CHLORAMPHENICOLS + COMBS</th>\n",
       "      <td>$26,328</td>\n",
       "      <td>$418,272</td>\n",
       "      <td>$425,949</td>\n",
       "      <td>$583,323</td>\n",
       "      <td>$324,733</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>J01M RIFAMPICIN AND RIFAMYCIN</th>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$2,872</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>S01N ANTICATARACTOGENICS</th>\n",
       "      <td>$2,290</td>\n",
       "      <td>$23,884</td>\n",
       "      <td>$12,811</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "      <td>$nan</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>313 rows  7 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                     2009_Sales      2010_Sales  \\\n",
       "ATC3                                                              \n",
       "A10C HUMAN INSULIN+ANALOGUES       $742,079,926  $8,839,139,374   \n",
       "L04B ANTI-TNF PRODUCTS             $901,405,875 $10,307,786,502   \n",
       "J05B ANTIVIRALS EXCL ANTI-HIV      $364,628,590  $3,259,218,483   \n",
       "J05C HIV ANTIVIRALS                $838,449,602  $9,361,722,160   \n",
       "N05A ANTIPSYCHOTICS              $1,459,445,588 $16,313,933,635   \n",
       "L01G MAB ANTINEOPLASTICS           $775,466,245  $8,327,409,055   \n",
       "C10A CHOLEST&TRIGLY.REGULATOR    $1,611,076,334 $17,869,762,169   \n",
       "N03A ANTI-EPILEPTICS               $562,699,135  $5,744,242,911   \n",
       "L03A IMMUNOSTIM AG EX INTFRON      $568,608,559  $6,613,290,644   \n",
       "L01H PROTEIN KINASE INH A-NEO      $241,684,926  $2,955,797,379   \n",
       "N06B PSYCHOSTIMULANTS              $597,512,843  $6,818,116,496   \n",
       "N02A NARCOTIC ANALGESICS           $811,640,663  $8,463,964,080   \n",
       "R03F B2-STIMULANTS+CORTICOIDS      $549,520,533  $6,049,238,716   \n",
       "A02B ANTIULCERANTS               $1,250,344,211 $12,899,609,092   \n",
       "L04X OTHER IMMUNOSUPPRESSANTS      $253,225,425  $2,814,007,313   \n",
       "A10N DPP-IV INHIB ANTIDIAB         $209,290,894  $2,660,315,158   \n",
       "N07X ALL OTHER CNS DRUGS            $78,479,069  $1,056,385,597   \n",
       "N06A ANTIDEPRESS.& MOOD STAB.    $1,114,790,703 $11,930,272,075   \n",
       "G03A HORMONAL CONTRACEPT SYST      $441,972,265  $4,832,167,207   \n",
       "R03G ANTICHOLINERGIC+B2-STIM       $287,234,413  $3,351,411,481   \n",
       "L03B INTERFERONS                   $312,838,538  $3,546,741,377   \n",
       "J07E VIRAL VACCINES                $250,298,291  $3,136,738,705   \n",
       "T02D DIABETES TEST                 $352,498,215  $3,740,369,928   \n",
       "B03C ERYTHROPOIETIN PRODUCTS       $596,696,011  $6,119,582,714   \n",
       "B01F DIRECT FACTOR XA INHIBITORS           $nan            $nan   \n",
       "R03A B2-STIMULANTS                 $284,106,805  $2,935,422,804   \n",
       "R03D CORTICOIDS                    $304,359,876  $2,608,827,766   \n",
       "A10S GLP-1 AGONIST ANTIDIAB         $61,978,790    $844,787,962   \n",
       "A07E INTESTINAL ANTI-INFLAMM       $168,280,644  $1,950,885,436   \n",
       "G04E ERECTILE DYSFUNCTION PRD      $196,471,259  $2,057,606,145   \n",
       "...                                         ...             ...   \n",
       "G03X OTH.SEX HORM.&SIMILAR             $702,545      $7,124,438   \n",
       "K02B STARCHES                        $1,606,515     $20,706,084   \n",
       "J03A SYSTEMIC SULPHONAMIDES            $522,225      $5,843,966   \n",
       "K05A IRRIGATING SOLUTIONS              $264,094      $2,976,474   \n",
       "T01G RADIODIAGNOSTIC AGENTS                $nan            $nan   \n",
       "R03C N-STEROIDAL RESP A-INFL           $251,509      $2,281,054   \n",
       "A07X OTHER ANTIDIARRHOEALS               $1,274         $53,900   \n",
       "K01A ELECTROLYTE SOLN=>100ML           $382,097      $3,764,913   \n",
       "G01D GYNAECOLOG ANTISEPTICS             $33,917        $316,459   \n",
       "C05B VARICOSE THERAPY,TOPICAL          $449,584      $2,792,942   \n",
       "J06G SPECF IMM-GLOB ANTI-BACT          $712,770      $4,821,608   \n",
       "N06D NOOTROPICS                            $nan            $nan   \n",
       "C02B A-HYPERT(NON VEG)+DIURET          $106,147      $1,003,446   \n",
       "K01B STANDARD SOLUTIONS                 $78,477      $1,209,659   \n",
       "K01E AMINO-ACID SOLUTIONS               $14,748        $278,890   \n",
       "H03C IODINE PREPARATIONS                $37,436      $1,412,212   \n",
       "K02A DEXTRANS                          $138,420      $1,774,903   \n",
       "A02C OTH STOMACH DISORDER PRD           $27,576        $438,167   \n",
       "K07A PERFUSION SOLUTIONS                $28,917        $191,961   \n",
       "J01L CARBENICILLIN+SIMIL.TYPE          $981,542      $9,009,489   \n",
       "K04B STANDARD SOLUTION <100ML           $25,860        $216,454   \n",
       "P03B INSECTICIDES & REPELLENTS             $nan            $319   \n",
       "C02C RAUWLF ALK+OTH A-HY HERB           $95,011      $1,037,018   \n",
       "K04C CALORIC SOLUTIONS <100ML                $3            $218   \n",
       "A03E A-SPASMA COMBINATIONS              $20,878        $225,224   \n",
       "A10D ANIMAL INSULINS                       $nan            $nan   \n",
       "A15A APPETITE STIMULANTS                 $8,207        $106,213   \n",
       "J01B CHLORAMPHENICOLS + COMBS           $26,328        $418,272   \n",
       "J01M RIFAMPICIN AND RIFAMYCIN              $nan            $nan   \n",
       "S01N ANTICATARACTOGENICS                 $2,290         $23,884   \n",
       "\n",
       "                                      2011_Sales      2012_Sales  \\\n",
       "ATC3                                                               \n",
       "A10C HUMAN INSULIN+ANALOGUES     $10,368,543,405 $12,029,319,586   \n",
       "L04B ANTI-TNF PRODUCTS           $11,599,115,081 $13,291,287,167   \n",
       "J05B ANTIVIRALS EXCL ANTI-HIV     $3,783,147,071  $4,416,735,597   \n",
       "J05C HIV ANTIVIRALS              $10,425,568,102 $11,362,532,422   \n",
       "N05A ANTIPSYCHOTICS              $18,445,943,730 $13,272,796,233   \n",
       "L01G MAB ANTINEOPLASTICS          $8,585,636,903  $9,130,107,622   \n",
       "C10A CHOLEST&TRIGLY.REGULATOR    $19,654,414,518 $15,190,739,932   \n",
       "N03A ANTI-EPILEPTICS              $6,023,663,290  $6,066,664,715   \n",
       "L03A IMMUNOSTIM AG EX INTFRON     $7,725,432,494  $8,179,401,022   \n",
       "L01H PROTEIN KINASE INH A-NEO     $3,661,904,516  $4,602,790,110   \n",
       "N06B PSYCHOSTIMULANTS             $7,976,391,249  $8,930,754,357   \n",
       "N02A NARCOTIC ANALGESICS          $8,334,870,709  $8,198,608,478   \n",
       "R03F B2-STIMULANTS+CORTICOIDS     $6,264,401,811  $6,595,761,925   \n",
       "A02B ANTIULCERANTS               $10,995,409,144 $10,220,295,809   \n",
       "L04X OTHER IMMUNOSUPPRESSANTS     $3,409,174,388  $4,006,017,323   \n",
       "A10N DPP-IV INHIB ANTIDIAB        $3,490,233,933  $4,427,911,104   \n",
       "N07X ALL OTHER CNS DRUGS          $1,334,038,125  $1,654,719,703   \n",
       "N06A ANTIDEPRESS.& MOOD STAB.    $11,288,913,834  $9,613,659,445   \n",
       "G03A HORMONAL CONTRACEPT SYST     $5,197,518,929  $5,379,145,035   \n",
       "R03G ANTICHOLINERGIC+B2-STIM      $3,878,841,608  $4,131,978,073   \n",
       "L03B INTERFERONS                  $3,858,289,859  $4,252,865,062   \n",
       "J07E VIRAL VACCINES               $3,320,007,856  $3,734,589,368   \n",
       "T02D DIABETES TEST                $3,794,634,292  $3,758,750,328   \n",
       "B03C ERYTHROPOIETIN PRODUCTS      $5,146,513,592  $4,175,084,291   \n",
       "B01F DIRECT FACTOR XA INHIBITORS     $17,031,766    $256,391,468   \n",
       "R03A B2-STIMULANTS                $3,133,424,137  $3,239,213,273   \n",
       "R03D CORTICOIDS                   $2,891,419,706  $3,083,902,172   \n",
       "A10S GLP-1 AGONIST ANTIDIAB       $1,204,950,250  $1,603,099,752   \n",
       "A07E INTESTINAL ANTI-INFLAMM      $2,216,173,210  $2,215,923,998   \n",
       "G04E ERECTILE DYSFUNCTION PRD     $2,162,266,078  $2,236,891,610   \n",
       "...                                          ...             ...   \n",
       "G03X OTH.SEX HORM.&SIMILAR            $6,802,315      $6,929,617   \n",
       "K02B STARCHES                        $20,642,050     $22,368,919   \n",
       "J03A SYSTEMIC SULPHONAMIDES           $6,032,996      $6,039,299   \n",
       "K05A IRRIGATING SOLUTIONS             $2,938,666      $2,839,832   \n",
       "T01G RADIODIAGNOSTIC AGENTS                 $nan        $639,600   \n",
       "R03C N-STEROIDAL RESP A-INFL          $1,618,751      $1,732,835   \n",
       "A07X OTHER ANTIDIARRHOEALS               $35,729         $46,092   \n",
       "K01A ELECTROLYTE SOLN=>100ML          $2,326,795      $2,198,333   \n",
       "G01D GYNAECOLOG ANTISEPTICS           $4,376,518      $1,415,275   \n",
       "C05B VARICOSE THERAPY,TOPICAL         $3,973,397      $8,062,444   \n",
       "J06G SPECF IMM-GLOB ANTI-BACT         $7,102,153      $4,860,107   \n",
       "N06D NOOTROPICS                          $38,187        $301,779   \n",
       "C02B A-HYPERT(NON VEG)+DIURET         $1,092,611      $1,242,050   \n",
       "K01B STANDARD SOLUTIONS                 $730,649        $579,845   \n",
       "K01E AMINO-ACID SOLUTIONS               $314,121        $226,097   \n",
       "H03C IODINE PREPARATIONS              $2,164,102      $1,304,628   \n",
       "K02A DEXTRANS                         $1,338,152      $1,504,886   \n",
       "A02C OTH STOMACH DISORDER PRD           $472,649        $377,113   \n",
       "K07A PERFUSION SOLUTIONS                 $23,940         $29,616   \n",
       "J01L CARBENICILLIN+SIMIL.TYPE         $6,086,181      $3,133,312   \n",
       "K04B STANDARD SOLUTION <100ML         $2,153,489         $13,142   \n",
       "P03B INSECTICIDES & REPELLENTS              $525          $2,137   \n",
       "C02C RAUWLF ALK+OTH A-HY HERB           $888,547        $549,178   \n",
       "K04C CALORIC SOLUTIONS <100ML                $35             $90   \n",
       "A03E A-SPASMA COMBINATIONS              $275,724        $348,084   \n",
       "A10D ANIMAL INSULINS                        $nan            $nan   \n",
       "A15A APPETITE STIMULANTS                 $37,557            $343   \n",
       "J01B CHLORAMPHENICOLS + COMBS           $425,949        $583,323   \n",
       "J01M RIFAMPICIN AND RIFAMYCIN               $nan            $nan   \n",
       "S01N ANTICATARACTOGENICS                 $12,811            $nan   \n",
       "\n",
       "                                      2013_Sales      2014_Sales  \\\n",
       "ATC3                                                               \n",
       "A10C HUMAN INSULIN+ANALOGUES     $15,409,739,180 $20,472,938,207   \n",
       "L04B ANTI-TNF PRODUCTS           $15,632,559,151 $19,523,048,388   \n",
       "J05B ANTIVIRALS EXCL ANTI-HIV     $3,583,822,947 $14,057,523,775   \n",
       "J05C HIV ANTIVIRALS              $12,481,200,605 $14,342,715,015   \n",
       "N05A ANTIPSYCHOTICS              $12,363,887,855 $14,595,378,779   \n",
       "L01G MAB ANTINEOPLASTICS          $9,853,747,190 $11,230,992,713   \n",
       "C10A CHOLEST&TRIGLY.REGULATOR    $12,535,464,617 $12,694,372,883   \n",
       "N03A ANTI-EPILEPTICS              $7,193,795,755  $8,509,607,219   \n",
       "L03A IMMUNOSTIM AG EX INTFRON     $8,604,649,157  $9,052,907,185   \n",
       "L01H PROTEIN KINASE INH A-NEO     $5,735,995,613  $7,479,903,265   \n",
       "N06B PSYCHOSTIMULANTS             $8,362,893,489  $8,325,607,275   \n",
       "N02A NARCOTIC ANALGESICS          $8,283,624,184  $8,855,397,919   \n",
       "R03F B2-STIMULANTS+CORTICOIDS     $7,537,576,296  $8,152,466,357   \n",
       "A02B ANTIULCERANTS               $10,533,571,606  $9,718,105,249   \n",
       "L04X OTHER IMMUNOSUPPRESSANTS     $5,130,979,450  $6,842,505,598   \n",
       "A10N DPP-IV INHIB ANTIDIAB        $5,290,779,829  $6,477,965,596   \n",
       "N07X ALL OTHER CNS DRUGS          $3,084,354,356  $5,640,242,676   \n",
       "N06A ANTIDEPRESS.& MOOD STAB.     $9,302,004,426  $6,868,586,539   \n",
       "G03A HORMONAL CONTRACEPT SYST     $5,386,697,726  $5,346,349,146   \n",
       "R03G ANTICHOLINERGIC+B2-STIM      $4,412,799,409  $4,733,172,409   \n",
       "L03B INTERFERONS                  $4,825,627,668  $4,713,002,069   \n",
       "J07E VIRAL VACCINES               $4,178,961,033  $4,666,146,125   \n",
       "T02D DIABETES TEST                $3,966,071,363  $4,155,525,929   \n",
       "B03C ERYTHROPOIETIN PRODUCTS      $4,153,201,377  $4,226,034,914   \n",
       "B01F DIRECT FACTOR XA INHIBITORS  $1,125,280,477  $2,616,374,746   \n",
       "R03A B2-STIMULANTS                $3,303,831,241  $3,561,669,607   \n",
       "R03D CORTICOIDS                   $3,444,502,714  $3,681,024,019   \n",
       "A10S GLP-1 AGONIST ANTIDIAB       $2,077,394,829  $2,673,656,401   \n",
       "A07E INTESTINAL ANTI-INFLAMM      $2,452,171,127  $2,825,894,007   \n",
       "G04E ERECTILE DYSFUNCTION PRD     $2,572,906,391  $2,966,493,044   \n",
       "...                                          ...             ...   \n",
       "G03X OTH.SEX HORM.&SIMILAR            $6,114,339      $4,958,442   \n",
       "K02B STARCHES                        $14,083,080      $6,239,741   \n",
       "J03A SYSTEMIC SULPHONAMIDES           $6,646,640      $5,702,515   \n",
       "K05A IRRIGATING SOLUTIONS             $2,753,392      $2,995,908   \n",
       "T01G RADIODIAGNOSTIC AGENTS           $3,456,960      $2,982,200   \n",
       "R03C N-STEROIDAL RESP A-INFL          $1,871,087      $2,186,784   \n",
       "A07X OTHER ANTIDIARRHOEALS            $1,208,338      $2,550,117   \n",
       "K01A ELECTROLYTE SOLN=>100ML            $526,589      $1,208,929   \n",
       "G01D GYNAECOLOG ANTISEPTICS           $1,431,201      $2,096,224   \n",
       "C05B VARICOSE THERAPY,TOPICAL         $4,830,263      $2,193,026   \n",
       "J06G SPECF IMM-GLOB ANTI-BACT         $2,639,025      $1,717,991   \n",
       "N06D NOOTROPICS                         $771,328      $1,131,840   \n",
       "C02B A-HYPERT(NON VEG)+DIURET         $1,250,800      $1,167,913   \n",
       "K01B STANDARD SOLUTIONS                 $535,163        $887,939   \n",
       "K01E AMINO-ACID SOLUTIONS               $418,660        $669,609   \n",
       "H03C IODINE PREPARATIONS                $645,194      $1,034,800   \n",
       "K02A DEXTRANS                         $1,104,920        $354,925   \n",
       "A02C OTH STOMACH DISORDER PRD           $400,188        $377,728   \n",
       "K07A PERFUSION SOLUTIONS                 $28,127        $140,705   \n",
       "J01L CARBENICILLIN+SIMIL.TYPE         $1,828,937      $2,100,345   \n",
       "K04B STANDARD SOLUTION <100ML             $5,086          $4,071   \n",
       "P03B INSECTICIDES & REPELLENTS            $2,152          $3,009   \n",
       "C02C RAUWLF ALK+OTH A-HY HERB             $1,391            $448   \n",
       "K04C CALORIC SOLUTIONS <100ML               $113              $7   \n",
       "A03E A-SPASMA COMBINATIONS              $139,144            $538   \n",
       "A10D ANIMAL INSULINS                        $nan         $11,358   \n",
       "A15A APPETITE STIMULANTS                    $nan            $nan   \n",
       "J01B CHLORAMPHENICOLS + COMBS           $324,733            $nan   \n",
       "J01M RIFAMPICIN AND RIFAMYCIN             $2,872            $nan   \n",
       "S01N ANTICATARACTOGENICS                    $nan            $nan   \n",
       "\n",
       "                                      2015_Sales  \n",
       "ATC3                                              \n",
       "A10C HUMAN INSULIN+ANALOGUES     $18,267,383,173  \n",
       "L04B ANTI-TNF PRODUCTS           $17,611,642,263  \n",
       "J05B ANTIVIRALS EXCL ANTI-HIV    $15,783,499,059  \n",
       "J05C HIV ANTIVIRALS              $12,249,956,153  \n",
       "N05A ANTIPSYCHOTICS              $10,949,869,451  \n",
       "L01G MAB ANTINEOPLASTICS          $9,945,900,325  \n",
       "C10A CHOLEST&TRIGLY.REGULATOR     $9,394,372,968  \n",
       "N03A ANTI-EPILEPTICS              $7,436,970,595  \n",
       "L03A IMMUNOSTIM AG EX INTFRON     $7,426,129,886  \n",
       "L01H PROTEIN KINASE INH A-NEO     $6,991,640,910  \n",
       "N06B PSYCHOSTIMULANTS             $6,684,808,696  \n",
       "N02A NARCOTIC ANALGESICS          $6,667,318,523  \n",
       "R03F B2-STIMULANTS+CORTICOIDS     $6,642,387,359  \n",
       "A02B ANTIULCERANTS                $6,419,058,846  \n",
       "L04X OTHER IMMUNOSUPPRESSANTS     $6,038,477,363  \n",
       "A10N DPP-IV INHIB ANTIDIAB        $5,802,403,288  \n",
       "N07X ALL OTHER CNS DRUGS          $5,074,300,641  \n",
       "N06A ANTIDEPRESS.& MOOD STAB.     $4,257,404,931  \n",
       "G03A HORMONAL CONTRACEPT SYST     $4,176,768,585  \n",
       "R03G ANTICHOLINERGIC+B2-STIM      $3,898,155,670  \n",
       "L03B INTERFERONS                  $3,751,979,572  \n",
       "J07E VIRAL VACCINES               $3,544,011,070  \n",
       "T02D DIABETES TEST                $3,308,853,329  \n",
       "B03C ERYTHROPOIETIN PRODUCTS      $3,185,703,803  \n",
       "B01F DIRECT FACTOR XA INHIBITORS  $3,068,029,527  \n",
       "R03A B2-STIMULANTS                $2,928,384,141  \n",
       "R03D CORTICOIDS                   $2,831,089,879  \n",
       "A10S GLP-1 AGONIST ANTIDIAB       $2,659,330,472  \n",
       "A07E INTESTINAL ANTI-INFLAMM      $2,582,281,872  \n",
       "G04E ERECTILE DYSFUNCTION PRD     $2,471,040,341  \n",
       "...                                          ...  \n",
       "G03X OTH.SEX HORM.&SIMILAR            $4,709,047  \n",
       "K02B STARCHES                         $4,272,752  \n",
       "J03A SYSTEMIC SULPHONAMIDES           $4,054,874  \n",
       "K05A IRRIGATING SOLUTIONS             $3,620,448  \n",
       "T01G RADIODIAGNOSTIC AGENTS           $3,216,200  \n",
       "R03C N-STEROIDAL RESP A-INFL          $2,714,422  \n",
       "A07X OTHER ANTIDIARRHOEALS            $2,320,079  \n",
       "K01A ELECTROLYTE SOLN=>100ML          $2,174,818  \n",
       "G01D GYNAECOLOG ANTISEPTICS           $1,858,737  \n",
       "C05B VARICOSE THERAPY,TOPICAL         $1,377,375  \n",
       "J06G SPECF IMM-GLOB ANTI-BACT         $1,332,386  \n",
       "N06D NOOTROPICS                       $1,013,603  \n",
       "C02B A-HYPERT(NON VEG)+DIURET           $738,118  \n",
       "K01B STANDARD SOLUTIONS                 $693,645  \n",
       "K01E AMINO-ACID SOLUTIONS               $637,357  \n",
       "H03C IODINE PREPARATIONS                $617,472  \n",
       "K02A DEXTRANS                           $425,073  \n",
       "A02C OTH STOMACH DISORDER PRD           $275,215  \n",
       "K07A PERFUSION SOLUTIONS                $156,979  \n",
       "J01L CARBENICILLIN+SIMIL.TYPE             $9,267  \n",
       "K04B STANDARD SOLUTION <100ML             $8,228  \n",
       "P03B INSECTICIDES & REPELLENTS            $2,580  \n",
       "C02C RAUWLF ALK+OTH A-HY HERB               $109  \n",
       "K04C CALORIC SOLUTIONS <100ML                $89  \n",
       "A03E A-SPASMA COMBINATIONS                   $50  \n",
       "A10D ANIMAL INSULINS                        $nan  \n",
       "A15A APPETITE STIMULANTS                    $nan  \n",
       "J01B CHLORAMPHENICOLS + COMBS               $nan  \n",
       "J01M RIFAMPICIN AND RIFAMYCIN               $nan  \n",
       "S01N ANTICATARACTOGENICS                    $nan  \n",
       "\n",
       "[313 rows x 7 columns]"
      ]
     },
     "execution_count": 61,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "typesum_df.sort_values('2015_Sales', ascending = False)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.4.3"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
